Literature DB >> 12826038

Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas--a preliminary study.

J Chasle1, T Delozier, Y Denoux, J Marnay, J-J Michels.   

Abstract

The aim of this study was to assess the levels of cell cycle regulatory proteins p21waf1 (p21), p53, Cyclin A, Cyclin D1 and Ki-67 to see whether they correlated with recurrence-free survival (RFS). From 1982 to 1996, 50 patients aged less than 51 years underwent lumpectomy followed by radiotherapy for a pure ductal carcinoma in situ (DCIS). For each case, the following immunohistochemical stains were carried out: Ki-67, Cyclin A, Cyclin D1, p53 and p21waf1 (p21). The percentage of positive nuclei was assessed. Multiple combinations of these factors were performed; in particular, we called the sum of Ki-67 and Cyclin A a global proliferation factor (GPF). Correlations with classical clinicopathological data were assessed. After a multivariate analysis, only GPF, Van Nuys Prognostic Index (VNPI) grade and mitotic index were independent predictive factors of recurrence in the whole population. In the population with close surgical margins, when the GPF level was less than the 25th percentile or more than the 75th percentile recurrence was low. In this preliminary study, GPF seems to be of interest to help in the decision process in the post-surgical management of the patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12826038     DOI: 10.1016/s0959-8049(02)00774-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  4 in total

Review 1.  The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.

Authors:  M Luke Marinovich; Lamiae Azizi; Petra Macaskill; Les Irwig; Monica Morrow; Lawrence J Solin; Nehmat Houssami
Journal:  Ann Surg Oncol       Date:  2016-08-15       Impact factor: 5.344

2.  Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.

Authors:  Sara A Lari; Henry M Kuerer
Journal:  J Cancer       Date:  2011-05-01       Impact factor: 4.207

3.  Biological Markers Predictive of Invasive Recurrence in DCIS.

Authors:  Sharon Nofech-Mozes; Jacqueline Spayne; Eileen Rakovitch; Harriette J Kahn; Arun Seth; Jean-Phillippe Pignol; Lavina Lickley; Lawrence Paszat; Wedad Hanna
Journal:  Clin Med Oncol       Date:  2008-01-22

4.  COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ.

Authors:  Swati Kulkarni; Deepa B Patil; Leslie K Diaz; Elizabeth L Wiley; Monica Morrow; Seema A Khan
Journal:  BMC Cancer       Date:  2008-01-31       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.